MHRA approves UK’s first new type of antibiotic for urinary tract infections
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
Inclacumab was generally well tolerated in THRIVE-131
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
The system, called GeneAgent, cross-checks its own initial predictions for accuracy against information from established, expert-curated databases
Trixeo is the first pMDI medicine in AstraZeneca’s portfolio to use the near-zero GWP propellant
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
Subscribe To Our Newsletter & Stay Updated